CalmiGo

NeuroTech Analytics releases industry-first report

Latest articles

The Sheekey Science Show – Aging Clocks

Aging clocks - how to measure biological age. I hope you have some time on you hands as today we will talk all about aging...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Over a third of Generation X have multiple health problems

More than one in three British adults are suffering from two or more chronic health conditions in middle age, such as recurrent back problems,...

Forget the arms race – it’s time for a longevity race

Professor Andrew Scott outlines how society needs to change in order to capitalise on multi-trillion dollar longevity dividend. Last week, we brought you the views...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...
Seno

Editor's picks

The Sheekey Science Show – Aging Clocks

Aging clocks - how to measure biological age. I hope you have some time on you hands as today we will talk all about aging...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Over a third of Generation X have multiple health problems

More than one in three British adults are suffering from two or more chronic health conditions in middle age, such as recurrent back problems,...
CalmiGo

Click the globe for translations.

New open-access analytical report profiles top technologies, sectors, trends, companies, investors, R&D hubs and influencers in the Global NeuroTech Industry

“Global NeuroTech Industry Landscape Overview 2020” is the inaugural report of NeuroTech Analytics, a new source of NeuroTech industry analytics; the report delivers market mapping and landscape analysis to identify the key players in NeuroTech, to understand the broad context in which they are operating, and how they are deploying their technology strategy.

NeuroTech Industry 2020 Landscape Overview
NeuroTech Industry 2020 Landscape Overview

“With the publication of this comprehensive analytical report on the global NeuroTech Industry, we bring NeuroTech.com deeper into the realm of quantitative and tangible industry analysis, benchmarking and forecasting within the rapidly-developing and diversifying NeuroTech sector,” said Alon Braun, Co-Founder of NeuroTech Analytics.

Last year we spoke with Bruce Yankner, professor of genetics at Harvard Medical School and co-director of the Paul F Glenn Center for the Biology of Aging, to explore neural tech and the role it can play in Longevity, he told us: “The idea that neural circuit activity in the brain can have far-reaching effects on lifespan is exciting, and raises the possibility of a previously unanticipated mode of regulation of the aging process.”

The analytics behind the report enable the identification of critical trends, technologies and approaches shaping the sector, and pinpoints the domains that are well served by existing players, as well as underrepresented areas lacking a critical mass of industry development. The market is definitely hotting-up.

“NeuroTech has enormous potential to disrupt a number of different industries and aspects of the human condition, from overcoming disability to enhancing cognitive performance, sleep, meditation, preventive health, Longevity and more. It is a rapidly developing frontier-technology driven sector complexified by its use of technologies like Artificial Intelligence, mathematics and data science that are evolving at breakneck speed,” said Dmitry Kaminskiy, Co-Founder of NeuroTech Analytics.

The Global Neurotech Industry is one of the most promising and prospective sectors of technology: annual growth of investment in neurotechnology is 31% while the average growth for life science investment, in general, is 12%.

Private capital funds invested more than $19 billion in NeuroTech companies since the year 2000. Corporations, investors and other counterparties who succeed to tap into the current wave of industry growth and development will gain essential competitive advantages in their struggle for new markets, audiences, funding and technologies.

Some NeuroTech subsectors are already well-established and mature, with practical implementations and products either already on the market or set to appear in the next several years, whereas other subsectors are still emerging, and dominated by early-stage startups.

Neurotech.com is the creation of Alon Braun from Riverbanks Solutions and Dmitry Kaminskiy from Deep Knowledge Group.

Image credit: Nathan R from Pixabay

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
CalmiGo

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
Seno

Related articles

Gerostate passes crowdfunding goal for antiaging drug platform

Longevitytech.fund joins investment round as Buck Institute start-up continues crowdfunding campaign to move antiaging drug candidates into mammalian studies. With around two weeks still remaining...

3D structure of all proteins? You’ll have to Google that!

By unlocking and sharing the secrets of protein structures, DeepMind could supercharge drug discovery – this could be one of the biggest contributions of...

Billionaire donates $220m for peak performance research

Salk Institute, UC San Diego and Stanford given $220 million by Wu Tsai Human Performance Alliance to research molecular underpinnings of peak human performance. A Salk...

Longevity senotherapeutics report: Insilico Medicine

Insilico – on a mission to accelerate senescence drug discovery and development by continuously inventing and deploying new AI technologies. Over the coming weeks, we...

Digitalising healthcare for aging-in-place

PCL Health is expanding its digital footprint with wearables designed to increase and improve remote health monitoring for aging-in-place solutions. DISCLOSURE: Longevity.Technology (a brand of...
Seno